Mesh Suture, Inc.

Mesh Suture, Inc. (MSi) is a Chicago-based medical device manufacturer specializing in innovative mesh suture technology. Founded by surgeons and led by Dr. Gregory Dumanian, the company draws on over 25 years of clinical research from Northwestern University's Feinberg School of Medicine. MSi's flagship product, DURAMESH™, is the first and only non-absorbable polypropylene mesh suture that combines traditional suture benefits with a unique mesh structure. DURAMESH™ distributes and diffuses tension during tissue closure while facilitating suture integration, reducing complications such as surgical site infections, fascial dehiscence, incisional hernia, and tendon rupture. The device strengthens over time and is available in multiple sizes (2-0, 0, 1, 2) with small and large needle options to support familiar surgical techniques across diverse procedures. MSi is ISO 13485:2016 certified and globally commercialized, having been recognized as one of the Top Surgical Device Companies of 2024 by MedTech Outlook.